These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 10383008
1. Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure. Vaziri ND, Deng G, Liang K. Nephrol Dial Transplant; 1999 Jun; 14(6):1462-6. PubMed ID: 10383008 [Abstract] [Full Text] [Related]
2. Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome. Liang K, Vaziri ND. Kidney Int; 1999 Aug; 56(2):621-6. PubMed ID: 10432401 [Abstract] [Full Text] [Related]
3. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure. Vaziri ND, Liang K, Parks JS. Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821 [Abstract] [Full Text] [Related]
4. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. Liang K, Oveisi F, Vaziri ND. Kidney Int; 1998 Mar; 53(3):626-30. PubMed ID: 9507207 [Abstract] [Full Text] [Related]
5. Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure. Kim C, Vaziri ND. Kidney Int; 2005 Mar; 67(3):1028-32. PubMed ID: 15698441 [Abstract] [Full Text] [Related]
6. Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure. Vaziri ND, Wang XQ, Liang K. Am J Physiol; 1997 Dec; 273(6):F925-30. PubMed ID: 9435681 [Abstract] [Full Text] [Related]
7. PTH-PTHrP receptor mRNA is downregulated in chronic renal failure. Tian J, Smogorzewski M, Kedes L, Massry SG. Am J Nephrol; 1994 Dec; 14(1):41-6. PubMed ID: 8017480 [Abstract] [Full Text] [Related]
8. Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure. Liang K, Vaziri ND. Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E676-81. PubMed ID: 12217884 [Abstract] [Full Text] [Related]
9. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. Klin M, Smogorzewski M, Ni Z, Zhang G, Massry SG. J Clin Invest; 1996 May 15; 97(10):2167-73. PubMed ID: 8636395 [Abstract] [Full Text] [Related]
10. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Vaziri ND, Liang K. Kidney Int; 1996 Dec 15; 50(6):1928-35. PubMed ID: 8943476 [Abstract] [Full Text] [Related]
13. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure. Vaziri ND, Liang K. Am J Physiol Renal Physiol; 2004 Nov 15; 287(5):F1038-43. PubMed ID: 15280162 [Abstract] [Full Text] [Related]
14. Apolipoprotein E-rich HDL binding to liver plasma membranes in copper-deficient rats. Hassel CA, Carr TP, Marchello JA, Lei KY. Proc Soc Exp Biol Med; 1988 Mar 15; 187(3):296-308. PubMed ID: 2831541 [Abstract] [Full Text] [Related]
15. Upregulation of fatty acid synthase gene expression in experimental chronic renal failure. Szolkiewicz M, Nieweglowski T, Korczynska J, Sucajtys E, Stelmanska E, Goyke E, Swierczynski J, Rutkowski B. Metabolism; 2002 Dec 15; 51(12):1605-10. PubMed ID: 12489075 [Abstract] [Full Text] [Related]
16. Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat. Morgado N, Rigotti A, Valenzuela A. Ann Nutr Metab; 2005 Dec 15; 49(6):397-406. PubMed ID: 16227687 [Abstract] [Full Text] [Related]